Contact: Kathryn Ruehle, 914-740-2100, email@example.com
Mary Ann Liebert, Inc. Launches Author Appreciation Month With Fully Open Content through April 13th
New Rochelle, NY, March 31, 2014—Mary Ann Liebert, Inc., publishers is proud to announce that it has designated April “Author Appreciation Month” to showcase the stellar work of its authors and increase the discoverability and readership of scholarly articles. The company will be announcing a number of special initiatives throughout the month of April that reinforce its commitment to supporting its community of authors and maximizing the impact of their published work. These activities include free access to all published content, Open Access article processing charge waivers, and complimentary membership to the exclusive AuthorCite® platform, among others.
The company is kicking off Author Appreciation Month with two full weeks, beginning today, of unprecedented open access to its entire portfolio of content, without limitation.
“Our portfolio contains well over 100,000 papers, and we are strongly committed to ensuring the widest dissemination of this critical information,” said Mary Ann Liebert, president and CEO of the company that bears her name. “Our mission to advance interdisciplinary and multidisciplinary research and clinical application is absolute; hence this important initiative.”
Visit the Mary Ann Liebert, Inc., publishers website to browse the entire collection of 80 peer-reviewed journals free of charge. Articles are available in various areas of science and medical research, including biotechnology, clinical medicine and surgery, neuroscience, women’s health, public health, and more. Free access is available until 11:59pm EST on April 13, 2014.
To receive alerts about forthcoming Author Appreciation Month activities, click here.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Human Gene Therapy, Tissue Engineering, Journal of Neurotrauma, BioResearch Open Access, and AIDS Research and Human Retroviruses. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.